Get the Stockscreener App
1.17
10.38%
0.11
Tela Bio Inc stock is traded at $1.17, with a volume of 161.61K.
It is up +10.38% in the last 24 hours and down -22.52% over the past month.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.
See More
Previous Close:
$1.06
Open:
$1.09
24h Volume:
161.61K
Relative Volume:
1.12
Market Cap:
$47.20M
Revenue:
$63.15M
Net Income/Loss:
$-40.30M
P/E Ratio:
-0.7006
EPS:
-1.67
Net Cash Flow:
$-44.47M
1W Performance:
+17.08%
1M Performance:
-22.52%
6M Performance:
-15.83%
1Y Performance:
-59.52%
1-Day Range:
$1.05
$1.18
1-Week Range:
$1.00
$1.25
52-Week Range:
$0.8645
$3.20
Tela Bio Inc Stock (TELA) Company Profile
Name
Tela Bio Inc
Sector
Industry
Phone
484-320-2930
Address
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
1.17 | 42.76M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-31-22 | Initiated | Lake Street | Buy |
| Dec-03-19 | Initiated | Canaccord Genuity | Buy |
| Dec-03-19 | Initiated | JMP Securities | Mkt Outperform |
| Dec-03-19 | Initiated | Jefferies | Buy |
| Dec-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Tela Bio Inc Stock (TELA) Latest News
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
How hedge fund analytics apply to TELA Bio Inc. stockBuy Signal & Expert Approved Trade Ideas - newser.com
How buybacks impact TELA Bio Inc. stock valuePortfolio Update Summary & Stepwise Swing Trade Plans - newser.com
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference - The Manila Times
TELA Bio (NASDAQ: TELA) to webcast Piper Sandler conference presentation on Dec. 3 - Stock Titan
What dividend safety score for TELA Bio Inc. stockJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Canaccord Genuity Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - MarketScreener
Canaccord Genuity Lowers Price Target on TELA Bio (TELA) to $4.0 - GuruFocus
Major Investment Alert: EW Healthcare Partners Fund 2 Acquires Millions in TELA Bio Stock - TipRanks
Owner EW Healthcare Partners Fund 2 LP Buys 3,604,000 ($4M) Of Tela Bio Inc [TELA] - TradingView
[Form 4] TELA Bio, Inc. Insider Trading Activity - Stock Titan
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio (NASDAQ: TELA) grants 30,200 RSUs and 25,000 stock options as inducement awards - Stock Titan
Does TELA Bio Inc. show high probability of rebound2025 Support & Resistance & Free Safe Capital Growth Stock Tips - newser.com
TELA Bio Appoints William Plovanic to Board - MSN
TELA Bio Reports Revenue Growth and Strategic Moves - MSN
TELA Bio’s Earnings Call: Growth Amid Challenges - TipRanks
Can TELA Bio Inc. stock deliver surprise earnings beatOil Prices & Target Return Focused Stock Picks - newser.com
TELA Bio, Inc. (NASDAQ:TELA) Q3 2025 Earnings Call Transcript - Insider Monkey
TELA Bio Set to Unveil Innovations at Piper Sandler’s Premier Healthcare Conference! - MSN
Citizens Maintains TELA Bio (TELA) Market Outperform Recommendation - Nasdaq
TELA Bio Secures $70M Loan for Growth Initiatives - TipRanks
TELA Bio Welcomes Jim Hagen with Strategic Equity Grant - MSN
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results By Investing.com - Investing.com South Africa
Piper Sandler lowers TELA Bio stock price target to $1.25 on soft Q3 results - Investing.com Nigeria
TELA Bio, Inc. Enter into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP - MarketScreener
[8-K] TELA Bio, Inc. Reports Material Event | TELA SEC FilingForm 8-K - Stock Titan
Analyst Matt O'Brien Reiterates Neutral Rating for TELA Bio (TEL - GuruFocus
Citizens Maintains TELA Bio (TELA) Rating, Lowers Price Target | - GuruFocus
These Analysts Cut Their Forecasts On TELA Bio After Q3 Earnings - Benzinga
TELA Bio stock price target lowered to $5 at Citizens on lower ASP - Investing.com Nigeria
TELA Bio reports 9% revenue growth in Q3, revises 2025 guidance - Investing.com Australia
Positive Sentiment Still Eludes TELA Bio, Inc. (NASDAQ:TELA) Following 26% Share Price Slump - simplywall.st
TELA Bio Q3 2025 Earnings Call Transcript - MarketBeat
TELA Bio Reports Q3 Revenue Growth and New Credit Facility - The Globe and Mail
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... By GuruFocus - Investing.com Canada
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Gr - GuruFocus
TELA Bio Inc (TELA) Q3 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions ... - Yahoo Finance
Tela Bio Inc Stock (TELA) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):